ADVERUM BIOTECHNOLOGIES
HQ - Redwood City, California
Summary
Adverum is developing a pipeline of intravitreal single-administration gene therapies with the aspiration of developing functional cures to restore vision and prevent blindness.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 197 M
Avg. Deal Size£ 197 M
Senior Management
Laurent Fischer
President and CEO
Jason Awe
Executive Director
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite